Top

Reactions Weekly

Published in:

01-02-2021 | Breast Cancer | Case report

Antineoplastics

Chronic myeloid leukaemia: case report

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Funakoshi S, et al. Incidence of Secondary Malignancy of Chronic Myeloid Leukemia during Treatment of Breast Cancer with Hormone Therapy. Gan to Kagaku Ryoho 48: 73-75, No. 1, Jan 2021. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/33468727/ [Japanese; summarised from a translation]

Title: Antineoplastics
Chronic myeloid leukaemia: case report
Publication date: 01-02-2021
Publisher: Springer International Publishing
Keywords: Breast Cancer
Breast Cancer
Imatinib
Chronic Myeloid Leukemia
Anastrozole
Exemestane
Fulvestrant
Cytostatic Therapy
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-91143-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Chronic myeloid leukaemia: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Ibuprofen

Brodalumab

Antineoplastics

Ciclosporin/everolimus

Colecalciferol/vitamin-D

Ceftriaxone potentially linked with risk of encephalopathy